You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Unfolding the Future: How Will mRNA Technology Change the Landscape of Vaccination?

  • Authors: Saul N. Faust, FRCPCH, PhD; Drew Weissman, MD, PhD
  • CPD Released: 3/30/2022
  • Valid for credit through: 3/30/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.50 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for non-US primary care physicians, infectious disease specialists, and pediatricians.

The goal of this activity is to increase knowledge of the scientific basis for the messenger RNA (mRNA) vaccines, and the ongoing trials for mRNA vaccines beyond COVID-19.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • mRNA vaccine platform
    • Advantages and limitations of mRNA vaccines vs traditional vaccines
    • mRNA vaccines in different disease indications beyond COVID-19


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Saul N. Faust, FRCPCH, PhD

    Professor of Paediatric Immunology and Infectious Diseases
    Director
    NIHR Southampton Clinical Research Facility
    University Hospital Southampton NHS Foundation Trust
    University of Southampton
    Southampton, United Kingdom

    Disclosures

    Grants for clinical research from: AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Merck & Co., Inc.; Pfizer Inc.; Valneva
    Advisor or consultant for: GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Merck & Co., Inc.; Pfizer Inc.; Sanofi; Seqirus
    Speaker or member of speakers bureau for: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ; Pfizer Inc.

  • Drew Weissman, MD, PhD

    Professor of Medicine
    Perelman School of Medicine
    University of Pennsylvania
    Philadelphia, Pennsylvania, United States

    Disclosures

    Independent contractor for: Aexerna
    Grants for clinical research from: BioNtech
    Advisor or consultant for: Arcuturus Therapeutics; Axerna; Capstan; Greenlight; Intellia; Pittsburgh ReLiver; RVAC Medicines; TFF Pharmaceuticals
    Royalties or patent beneficiary: BioNtech; Moderna
    Stocks, stock options, or bonds from: Arcuturus Therapeutics; Axerna; Capstan; Greenlight; Intellia; Pittsburgh ReLiver; RVAC Medicines; TFF Pharmaceuticals
    Ownership of an ineligible company: Aexerna; Capstan; Pittsburgh ReLiver

Editors

  • Shanthi Voorn, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Shanthi Voorn, PhD, has disclosed no relevant financial relationships.

  • Diana Lucifero, PhD

    Scientific Content Manager, WebMD Global, LLC

    Disclosures

    Disclosure: Diana Lucifero, PhD, has disclosed no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Unfolding the Future: How Will mRNA Technology Change the Landscape of Vaccination?

Authors: Saul N. Faust, FRCPCH, PhD; Drew Weissman, MD, PhDFaculty and Disclosures

CPD Released: 3/30/2022

Valid for credit through: 3/30/2023

processing....

Educational Impact Challenge

The goal of this activity is to increase knowledge of the scientific basis for the messenger RNA (mRNA) vaccines, and the ongoing trials for mRNA vaccines beyond COVID-19.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.